corresponds to the news. The news got big reviews if related to price appreciation but that kind of run makes no sense to me except that it proves that the MM's can take a stock where they want.
OSIP ain't a cancer cure and the trial data leaves much to be desired. We won't be up here too long once the weakness arrives.
Currently $92 in AH.
mb
***Searching and buying tiny companies with an edge for future growth at low prices***